NCT06372587 · RECRUITING
Next-Generation alzheImer'S Therapeutics
This trial is not testing a drug in people — it is a lab study. Researchers will take a small skin sample from people with Alzheimer's, convert those skin cells into living neurons in a dish, and then test specially engineered proteins designed to strengthen the connections between brain cells. It is classified as Phase NA, meaning it is preclinical research, not yet a human treatment trial. Details on long-term direction are still early.
You may qualify if
- Manifest clinical criteria for probable AD;
- Age between 18 and 80 years;
- Signed informed consent obtained;
You're excluded if
- Patients suffering from other neurological diseases;
- Patients with coagulation disorders or in treatment with anticoagulant drugs;
- Patients suffering from dermatological diseases and connective tissue diseases;
- Patients suffering from other organic, psychiatric diseases or laboratory abnormalities could preclude participation or invalidate the study results;
- Inability to give informed consent.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-04-18